FUSOGENIX
PIPELINE
ABOUT
NEWS
CONTACT
News & Publications
September 7, 2021
Entos’ COVID-19 DNA Vaccine Candidate Approved for Phase 2 Clinical Trial in South Africa
Published by:
Perrin Beatty
July 7, 2021
Canadian Companies Entos Pharmaceuticals and Montrium Join Forces to Drive Clinical Innovation
Published by:
Perrin Beatty
May 18, 2021
Recruitment Update for the Phase 1 Clinical Trial of Entos’ Made in Canada DNA Vaccine for COVID-19
Published by:
Perrin Beatty
April 15, 2021
April 15 Marks Start of Phase I trial of Entos' COVID-19 DNA Vaccine with First Recruits
Published by:
Perrin Beatty
March 30, 2021
Made-in-Alberta COVID-19 vaccine candidate headed for clinical trials
Published by:
Entos Pharmaceuticals
February 25, 2021
Entos Partners with ACTM and the Ottawa Hospital's BMC to Manufacture and Ready its COVID-19 DNA Vaccine for Clinical Trials
Published by:
Perrin Beatty
November 9, 2020
Propel(x) Presents: The Path to a COVID-19 Vaccine Dec 11, 9 am PT
Published by:
Perrin Beatty
November 9, 2020
Science on Tap: Demystifying COVID-19 Vaccines Nov 9, 7 pm MST, http://twose.ca/sciencetap
Published by:
Perrin Beatty
October 27, 2020
Entos Working with Applied Pharmaceutical Innovation to Enable In-house Development and Manufacturing Capability of COVID-19 DNA Vaccine
Published by:
Perrin H Beatty
October 23, 2020
Entos Pharmaceuticals Awarded up to $5M in NRC IRAP funding to Conduct Phase I Clinical Trial of COVID-19 DNA Vaccine
Published by:
Perrin H Beatty
March 18, 2020
Entos Pharmaceuticals Is Developing a DNA Vaccine Against COVID-19 Using Its Fusogenix Nanomedicine Platform
Published by:
Entos Pharmaceuticals
December 20, 2019
HICKS ON BIZ: The University of Alberta’s next big thing
Published by:
Graham Hicks
October 1, 2019
IPA and Entos to Collaborate on Immuno-oncology Discovery Research
Published by:
Entos
November 1, 2018
Entos Pharmaceuticals joins JLABS San Diego
Published by:
Entos Pharmaceuticals
July 2, 2018
Entos awarded entry into the Merck Invention Accelerator
Published by:
Entos Pharmaceuticals
March 30, 2018
Entos and Oisin Bio Announce Fusogenix License for SENSOlytics™
Published by:
Entos Pharmaceuticals
June 26, 2018
Entos and Oisin Bio Launch OncoSenX: A Spinoff Company Targeting Cancer
Published by:
John D. Lewis, PhD
November 13, 2018
Precision Nanosystems and Entos Pharmaceuticals sign license agreement
Published by:
PRESS RELEASE (Precision NanoSystems)
Entos Pharmaceuticals
Unit 4550, 10230 Jasper Avenue
Edmonton, Alberta, Canada
T5J 4P6
Email:
info@entospharma.com
Name
Email Address
Company Name
Message
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
